News
Dianthus Therapeutics announces positive Phase II results for Claseprubart in myasthenia gravis, highlighting best-in-class potential.
Voyager Therapeutics, Inc. ( NASDAQ: VYGR) Citi's Biopharma Back to School Conference September 2, 2025 4:00 PM EDT ...
Transformative optogenetics technology allows for spatial and temporal control of cellular activity, enhancing research in ...
The vendor community represents a fascinating cross-section of humanity – retired collectors turning passions into side businesses, professional dealers with encyclopedic knowledge, families clearing ...
Essentially all cells in an organism's body have the same genetic blueprint, or genome, but the set of genes that are ...
3d
News Medical on MSNNew method calculates rate of gene expression to understand cell fate
How rapidly gene expression in a single cell changes over time can provide insight into how cells might become more specialized. A new method to calculate RNA velocity, developed by researchers at ...
MSD is preparing to take on Takeda in the dengue fever vaccine market, moving its V181 candidate into phase 3.
It’s probably a good idea to ditch your black plastic utensils, since they may expose you to harmful chemicals. Here’s what to use instead.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results